-
Metabolically-active visceral abdominal fat linked to signs of Alzheimer’s. However, given its propensity to contribute to heart disease and diabetes risk, these factors are likely a major contributing factor too.
Medical Mythbusting Commentary for December 3, 2024 Source:Belly fat linked to signs of Alzheimer’s 20 years before symptoms begin, study says
-
Wegovy (semaglutide) now approved by Health Canada to reduce the risk of non-fatal heart attack in people with known cardiovascular disease in addition to its use for weight loss management.
Medical Mythbusting Commentary for November 28, 2024 Source:Wegovy is a weight-loss drug. Health Canada says it can now be used to curb heart-attack risk
-
Having “skinny genes” does not imply that stable weight and health are a given. Nor did the study provide conclusive proof that they play a major role in weight stability.
Medical Mythbusting Commentary for October 22, 2024 Source:Does having ‘skinny genes’ mean you can skip exercise and diet? Reference:Genotypic Variations Associated with Changes in Body Mass in Response to Endurance Training
-
How various treatments and strategies influence the physiology of the weight-loss plateau
Medical Mythbusting Commentary for April 24, 2024 Source:Here’s when your weight loss will plateau, according to science Reference:Physiology of the weight-loss plateau in response to diet restriction, GLP-1 receptor agonism, and bariatric surgery
-
Mothers with obesity at greater risk of stillbirth: Canadian study
Medical Mythbusting Commentary for March 6, 2024 Source:Mothers with obesity at greater risk of stillbirth: Canadian study Reference:The impact of isolated obesity compared with obesity and other risk factors on risk of stillbirth: a retrospective cohort study
-
A new study, published in the journal Qualitative Health Research, found that yo-yo dieting or weight cycling can have long-lasting negative effects on dieters. No new ground here. Well known physiologic and mental health effects.
Medical Mythbusting Commentary for February 2, 2024 Source:‘Medically unnecessary’ diets risk a ‘lifelong struggle’ of yo-yo dieting, ‘real harm’: shocking study Reference:A Qualitative Model of Weight Cycling
-
Could a vibrating, ingestible capsule help treat obesity? Not likely due to logistical, physiological, lifestyle factors, and whether animal models are transferable to humans.
Medical Mythbusting Commentary for January 3, 2024 Source:Could a vibrating, ingestible capsule help treat obesity? Reference:A vibrating ingestible bioelectronic stimulator modulates gastric stretch receptors for illusory satiety
-
Obesity drug Wegovy cut risk of serious heart problems by 20 per cent, study finds
Medical Mythbusting Commentary for November 13, 2023 Source:Obesity drug Wegovy cut risk of serious heart problems by 20 per cent, study finds Reference:Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
-
Ozempic and similar drugs linked to gastrointestinal conditions: B.C. researchers. Already known but needs context about rarity of some of the side effects versus the beneficial health outcomes when assessing overall risk of its use.
Medical Mythbusting Commentary for October 6, 2023 Source:Ozempic and similar drugs linked to gastrointestinal conditions: B.C. researchers